Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids

European Oncology and Haematology - United Kingdom
doi 10.17925/eoh.2015.11.02.100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
2010English

Inhibition of the Mammalian Target of Rapamycin (mTOR) in Advanced Pancreatic Cancer: Results of Two Phase II Studies

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases

Biomedical Journal
Medicine
2013English

Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2017English

New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists

Breast Cancer Research
Cancer ResearchOncology
2004English

Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2009English

Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation

Journal of Neuroscience
Neuroscience
2009English

Systemic Inhibition of Mammalian Target of Rapamycin Inhibits Fear Memory Reconsolidation

Neurobiology of Learning and Memory
Cognitive PsychologyBehavioral NeuroscienceExperimentalCognitive Neuroscience
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy